Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01511302 · ClinicalTrials.gov registry record · Phase 1
Study of Inhaled RNS60 in Combination With Budesonide to Treat Mild to Moderate Asthma
A Phase 1 study, sponsored by Revalesio Corporation.
- Completed
- Registry status
- Phase 1
- Development phase
- 65
- Enrollment target
NCT01511302: Completed Phase 1 study, sponsored by Revalesio Corporation.
NCT01511302 is a Phase 1 study that has completed, run by Revalesio Corporation. The registered enrollment target is 65 participants, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01511302, a Phase 1 study, has completed, sponsored by Revalesio Corporation.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 65 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether RNS60, in combination with budesonide, is safe in mild to moderate asthmatics when taken by nebulization over a 28-day period, compared to a 28-day control period.
Primary Outcome
Evidence that RNS60 in combination with budesonide does not cause bronchoconstriction, as measured by FEV1 scores.
Interventions
- DRUG Normal Saline
- DRUG Budesonide
- DRUG RNS60
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2012-06 |
| Est. Completion | 2013-05 |
| Phase | Phase 1 |
What the finished NCT01511302 record still lists
NCT01511302 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 65 participants, a relatively small participant target, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target.
The record links to 0 conditions, and to 3 interventions - of which Normal Saline is the first listed.
NCT01511302 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01511302 about?
NCT01511302 is a clinical study titled "Study of Inhaled RNS60 in Combination With Budesonide to Treat Mild to Moderate Asthma". The purpose of this study is to determine whether RNS60, in combination with budesonide, is safe in mild to moderate asthmatics when taken by nebulization over a 28-day period, compared to a 28-day control period.
What is the current status of trial NCT01511302?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 65 participants. The study started on 2012-06. Estimated completion is 2013-05.
What interventions are being tested in trial NCT01511302?
The interventions under investigation include: Normal Saline (DRUG), Budesonide (DRUG), RNS60 (DRUG).
Who is sponsoring clinical trial NCT01511302?
This trial is sponsored by Revalesio Corporation, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01511302's enrollment target sits among peer trials
65 798th of 2000 higher than 1,193 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia